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Do people with epilepsy know more about the condition than people without epilepsy? 
T. Duthie*, S. Jarvie+ & H. Kent’ 
* Glaxo Welcome UK Ltd, Uxbridge, Middlesex, UK, ‘Department of Clinical Psychology The Grail 
Street Centre, Glasgow, UK and $British Epilepsy Association, Anstey House, Leeds, UK 
The level of knowledge of epilepsy among patients has been shown to be key to the management of the condition. However, 
few studies have assessed the level of knowledge of epilepsy in a large population sample. The objectives of this study 
(which was part of a larger research project) were first to compare the level of epilepsy-related knowledge between people 
with epilepsy and people without epilepsy in a general population. Secondly, to ascertain whether people with epilepsy feel 
satisfied with their knowledge of the condition and with their access to information on the condition. 
A questionnaire containing the Epilepsy Knowledge Profile---General (EKP-G) and additional questions on information 
access was designed and pilot tested. The additional questions were only given to the epilepsy sample. The final questionnaire 
was sent by post to a general population sample of 893 people with epilepsy and 1200 people without epilepsy. The non- 
epilepsy sample was drawn to match the demographics of the epilepsy sample. 
Responses from 287 people with epilepsy and 383 people without epilepsy were received, representing a response rate 
of 32.1% and 32.0% respectively. The mean number of correct responses to the questionnaire are: people with epilepsy 
(n = 287), medical (n = 34), 25.6 (75.3%) social (n = 21), 14.5 (69%), total (n = 55), 40.2 (73.1%); people without 
epilepsy (n = 383), medical (n = 34) 25.6 (75.3%), social (n = 21) 14.3 (68.1%), total (n = 55) 39.9 (72.5%). 
The results from the questionnaire indicate that there is no statistically significant difference in the medical knowledge 
(P = 0.31) or the social knowledge (P = 0.15) of epilepsy, between the two samples. The relationship between knowledge 
levels and the epilepsy sample’s satisfaction with their understanding of the condition will be explored. The findings from 
the study will generate suggestions to improve the focus and target of information provided on epilepsy. In addition, the 
results will help patient organizations to identify issues for future campaigns. 
Correlation of l1 C-FMZ-PET and 3H-FMZ autoradiography in temporal-lobe epilepsy 
M.J. Koepp, K.S.P. Hand, M.l? Richardson, N.G. Bowery & J.S. Duncan 
Epilepsy Research Group, Institute of Neurology, Queen Square, London, UK 
We used llC-Flumazenil (FMZ) PET and 3H-FMZ autoradiography in patients with mesial temporal lobe epilepsy (mTLE) 
to compare in viva and ex viva determination of central benzodiazepine receptors (cBZR). Comparing autoradiography and 
quantitative neuropathology we demonstrated that there is loss of cBZR in CA1 over and above loss of neurons. In order 
to determine cBZR density within the body of the hippocampus we applied an MRI-based, four-compartment method for 
partial volume effect (PVE) correction to ” C-FMZ volume of distribution (FMZ-Vd) images from 10 patients with refractory 
mTLE due to unilateral, histologically verified hippocampal sclerosis (HS) and 15 age-matched healthy volunteers. Saturation 
autoradiography was performed in the hippocampal specimens from the same patients and six controls with calculation of 
receptor availability (Bniax). Reductions of FMZ-Vd after correction for PVE were compared with reductions of Bmax in 
relation to available control data. FMZ-Vd in the body of the epileptogenic hippocampus was reduced by a mean of 41.7% 
compared with healthy volunteers. FMZ-B max determined autoradiographically in available hippocampal tissue was reduced 
by a mean of 41.2% compared to normal control data. In conclusion, down-regulation of cBZR on remaining neurones in 
HS can be detected in viva using ’ ‘C-FMZ PET corrected for PVE. 
Memory testing with intra-carotid sodium amytal: A non-mnestic factor 
S. Oxbury, E. Burkitt, J.M. Oxbury, & A.J. Molyneux 
The Radcliffe Infirmary, Oxford, UK 
Intracarotid sodium amytal (ISA) inactivates the injected hemisphere enabling measurement of the mnestic capacity of the 
other. It is used to check that the hemisphere contralateral to planned temporal lobe surgery (TLS) is free from pathology 
which might cause postoperative amnesia. An apparently normal non-dominant hemisphere (ND) may score unexpectedly 
low on memory tests, possibly because it has a lower capacity than the dominant hemisphere (D) or because incidental 
effects of D injection, e.g. aphasia, complicate assessment. We therefore analysed the post-recovery scores of 22 pre-TLS 
patients for recognition of eight three-dimensional common objects, initially presented immediately after ISA injection (175- 
200 mg), according to whether the non-injected (i.e. functioning) side was ND or D and pathological or intact. We also 
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analysed scores for eight patients tested identically following amytal (30-40 mg) injected directly into a posterior cerebral 
artery (PCA), to the inactivate hippocampus without causing aphasia. Mean scores (maximum = 8) by dominance/pathology 
were: for ISA normal D = 6.4 ND = 4.2, pathological D = 35 ND = 21; for PCA, normal D = 7.5 ND = 7.7, pathological 
D = 5.0 ND = 2.0. 
On ISA normal D vs. ND differ significantly (P < 0.05). The difference disappears on PCA. So, it is not due to primarily 
mnestic factors, and should be allowed for in assessing ND normality on ISA. 
impaired sensorimotor gating in patients with non-epileptic seizures 
H.R. Pouretemad*, P.J. Thompson? & P.B.C. Fenwick* 
*Clinical Neurophysiology Section, Department of Psychological Medicine, Institute of Psychiatry 
+ Department of Neuropsychology, institute of Neurology, University of London, London, UK 
The aim of the study was to identify possible disturbances of sensorimotor gating and of habituation of the eye-blink response 
in patients with non-epileptic seizures (NESS). Prepulse inhibition (PPI), as an operational measure of sensorimotor gating 
and habituation was studied in 21 patients with NESS and 22 healthy controls. Six NESS patients were taking anti-epileptic 
drugs (AEDs) at the time of testing. The PPI was significantly impaired in the NESS group compared with the controls 
(P < 0.05), with deficits being greater in unmedicated patients (P = 0.01). There was a trend for medicated NESS patients 
to show higher PPI than unmedicated patients, but this was not significant (P = 0.08). Habituation was intact in both 
medicated and unmedicated NESS patients. It is proposed that deficits of information processing related to sensorimotor 
gating in patients with NESS may be associated with abnormalities within the limbic system-basal ganglia circuitry which 
have been shown to be the substrate of ‘gating’ assessed by PPI. This study suggests that such impairment may be improved 
by AEDs. It was also found that anxiety had a role in the deterioration of PPI in the NESS group. 
Vestibulogenic ‘pseudoseizures’ 
PA. Savundra, R.A. Davies & L.M. Luxon 
National Hospital for Neurology and Neurosurgery; Queen Square, London, UK 
Eight cases are presented. All the patients experienced bouts of altered consciousness, five had the diagnosis of epilepsy. 
Features, which had suggested the diagnosis of epilepsy included black-outs, trance-like behaviour or unresponsiveness, gaze 
fixation, urinary incontinence and disordered behaviour during the bouts. 
After comprehensive neurological and vestibular testing the diagnosis was revised. A history of vertigo, defined as the 
illusion ofmovement, preceding or following the ictus, the frequency of the attacks with little cognitive dysfunction but with a 
greater impact on handicap, the lack of response to anticonvulsants and, in some cases a normal electroencephalogram (EEG) 
or one with non-specific features raised doubts about the diagnosis. Positive findings included the mimicking of symptoms 
during the Hallpike manoeuvre and bithermal caloric tests. During these tests, hyperventilation, gaze fixation, vigorous 
jactitation, altered responses, apparent confusion, and urinary incontinence occurred. However, no abnormal neurological 
signs were present, apart from the classical signs of benign paroxysmal positional vertigo (Case I) and a canal paresis. In 
three patients, an EEG during bithermal caloric testing revealed no epileptiform activity despite behaviour typical of the 
attacks. 
The diagnosis of vestibulogenic ‘pseudoseizures’ is a diagnosis by exclusion. Vestibular pathology can be treated. The 
diagnosis does not exclude the possibility of co-existent epilepsy. Patients with epilepsy, who have vertigo, should have a 
comprehensive neuro-otological examination. 
The relationship between recurrent seizures and mesial temporal sclerosis 
H. Salisbury* & W. Squiert 
*Department of Clinical Pharmacology, and 7 Department of Neuropathology Radcliffe Infirmary; 
Oxford, UK 
We studied the clinical histories and neuropathology of 17 patients with intractable epilepsy associated with infarction of 
the middle cerebral artery territory who underwent anatomical hemispherectomy. In 6 of the 17 cases mesial temporal 
